BlackRock Institutional Trust’s CorMedix CRMD Stock Holding History

BlackRock Institutional Trust’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$921K	Hold	120,384	–	–	﹤0.01%	3310
2016 Q3	$1.52M	Buy	120,384 +21,400	+22%	+$200K	﹤0.01%	3148
2016 Q2	$985K	Sell	98,984 -50,132	-34%	-$763K	﹤0.01%	3310
2016 Q1	$1.98M	Sell	149,116 -563	-0.4%	-$5.47K	﹤0.01%	3049
2015 Q4	$1.52M	Buy	149,679 +4,825	+3%	+$55.6K	﹤0.01%	3213
2015 Q3	$1.44M	Buy	144,854 +64,318	+80%	+$992K	﹤0.01%	3217
2015 Q2	$1.56M	Buy	80,536 +58,336	+263%	+$2M	﹤0.01%	3211
2015 Q1	$1.09M	Buy	22,200 +20,969	+1,703%	+$497K	﹤0.01%	3318
2014 Q4	$12K	Buy	+1,231	New	+$9.8K	﹤0.01%	3847

Other funds holding CRMD

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GLRA

Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Spot Trading Chicago, Illinois $5.81B AUM 22.41% 1-Year Est. Return

BlackRock Institutional Trust's CRMD Position: Q4 2016 in Review

BlackRock Institutional Trust held its CorMedix (CRMD) position steady in Q4 2016 at 120,384 shares worth $921K. The position accounts for ﹤0.01% of the portfolio, ranked #3310.

BlackRock Institutional Trust first reported a position in CRMD in Q4 2014 and has held it in 9 quarters since. The position peaked at $1.98M in Q1 2016. 38 funds tracked by Wall St. Rank hold CRMD as of Q4 2016.

BlackRock Institutional Trust held 120,384 shares of CorMedix worth $921K as of Q4 2016.
BlackRock Institutional Trust left its CorMedix share count unchanged in Q4 2016.
CorMedix made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3310 holding.
BlackRock Institutional Trust first reported a position in CorMedix in Q4 2014 and has held it in 9 quarters since.
BlackRock Institutional Trust's CorMedix position peaked at $1.98M in Q1 2016.
38 funds tracked by Wall St. Rank held CorMedix as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.